Latest PHAS reports update at 2022-08-12: 2022-Q22022-Q12021-Q4
PhaseBio Pharmaceuticals logo
PhaseBio Pharmaceuticals PHAS
$ 0.13 7.4%

PhaseBio Pharmaceuticals EBITDA per Share 2011-2024 | PHAS

Annual EBITDA per Share PhaseBio Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-2.4 -2.87 -1.44 -3.68 - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.44 -3.68 -2.6

Quarterly EBITDA per Share PhaseBio Pharmaceuticals

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - -0.49 -0.36 - -0.59 -0.42 -0.8 - -0.7 -0.83 -0.49 - -0.4 -0.34 -0.3 - -6.5 -5.43 -3.82 - -2.46 - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-0.3 -6.5 -1.6